Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

One person on a computer, working in a group of people

PRWeek: Budget Plan 2026—Balancing a Focus on AI with Human Connection

Brands in Motion "They want honesty, direction and clarity" | We. Communications

PRovoke: Brands in Motion "They Want Honesty, Direction, and Clarity"

PRWeek: Melissa Waggener Zorkin Named in 2022 Power List

Laura Gillen headshot | We. Communications

PRWeek: We. Communications Names New UK Managing Director

Schoen Clinic logo on a brick wall | We. Communications

Schoen Clinic UK Appoints We. for Integrated Comms Brief

Lockup of logos and abstract blue background | We. Communications

We. and ROKK Solutions Join Forces to Launch AI Partnership